- Home
- EBMT vs INMB Comparison
EBMT vs INMB Comparison
Compare EBMT & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- INMB
- Stock Information
- Founded
- EBMT 1922
- INMB 2015
- Country
- EBMT United States
- INMB United States
- Employees
- EBMT N/A
- INMB N/A
- Industry
- EBMT Major Banks
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- EBMT Finance
- INMB Health Care
- Exchange
- EBMT Nasdaq
- INMB Nasdaq
- Market Cap
- EBMT 120.7M
- INMB 123.0M
- IPO Year
- EBMT N/A
- INMB 2019
- Fundamental
- Price
- EBMT $15.79
- INMB $5.46
- Analyst Decision
- EBMT
- INMB Buy
- Analyst Count
- EBMT 0
- INMB 1
- Target Price
- EBMT N/A
- INMB $22.00
- AVG Volume (30 Days)
- EBMT 10.1K
- INMB 362.7K
- Earning Date
- EBMT 10-22-2024
- INMB 10-30-2024
- Dividend Yield
- EBMT 3.61%
- INMB N/A
- EPS Growth
- EBMT N/A
- INMB N/A
- EPS
- EBMT 1.08
- INMB N/A
- Revenue
- EBMT $80,564,000.00
- INMB $85,000.00
- Revenue This Year
- EBMT N/A
- INMB N/A
- Revenue Next Year
- EBMT $7.72
- INMB N/A
- P/E Ratio
- EBMT $14.61
- INMB N/A
- Revenue Growth
- EBMT N/A
- INMB N/A
- 52 Week Low
- EBMT $11.26
- INMB $4.81
- 52 Week High
- EBMT $17.65
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- EBMT 62.76
- INMB 44.41
- Support Level
- EBMT $15.49
- INMB $5.09
- Resistance Level
- EBMT $15.85
- INMB $5.73
- Average True Range (ATR)
- EBMT 0.25
- INMB 0.32
- MACD
- EBMT -0.04
- INMB 0.09
- Stochastic Oscillator
- EBMT 56.67
- INMB 69.52
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.